Home › Stories › Stocks
🔴 Fake hot

Moderna sheds $24 billion as cancer vaccine data is sold

A 42% cut in melanoma death or recurrence drew a sell-the-news reaction, not a rally.

Price at publication$202.63
Move-17.6%
Buzz velocity2.7×

What's happening

Moderna and Merck reported that their mRNA cancer vaccine cut death and recurrence by 42% in a melanoma trial. Reuters says Moderna shed about $24 billion as the data triggered a 'sell-the-news' retreat. A Handelsblatt post cites a drop of up to 26% after a data leak, and r/wallstreetbets has a thread saying the stock crashed 20% on reportedly leaked data. Merck and Moderna are already engaging with regulators.

The numbers

MRNA trades at $202.63, down 17.57%, with 19 mentions in 24 hours. Velocity is 2.7 across 4 sources, with 11 recent mentions. Press reports put the drop between 20% and 26% at its worst, so it has recovered a little since.

Our read

Chatter is high and the price is falling, so the attention isn't turning into buying. The science is the good news and the stock is the bad news. Whether the leak or a sell-the-news reaction drove it isn't settled in the evidence. Watch for regulatory filings and whether the stock holds the post-drop level.

Sources we checked

See today's live board

This story is frozen as published on October 24, 2026. The live board shows what is moving right now, scored against real money.

Open this story live → See today's live board

Earlier on Moderna

More Stocks stories

Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything — you decide.

Get Sort Brick Daily - free, every evening

One short email every evening: what really moved, what was only noise, and what we logged first, with the times. Free. Information, not investment advice.

No spam. One click to unsubscribe. Sent by Sort Brick.